Impact of glucosamine supplementation on gut health, microbiota and metabolome

TSI Group0 个研究点目标入组 11 人开始时间: 2021年6月8日最近更新: 2021年7月21日

适应症

试验速览

2021 results in https://doi.org/10.3390/nu13072180 (added 06/07/2021)

•1. Between the ages of 18 – 50 years
•2. Body mass index between 18.5 – 27 kg/m²
•3. Weight stable for the past three months (less than 5% variation in body mass)
•4. Free from all cardiovascular, pulmonary, autoimmune, musculoskeletal, gastrointestinal, psychological, or other diseases or disorders, as reported in their medical history

•1. Diagnosed with or were being treated for celiac disease, lactose intolerance, digestive insufficiencies, or other gastrointestinal complications such as irritable bowel syndrome, ulcerative colitis, etc.
•2. A current smoker or had quit within the past six months
•3. Currently using anabolic steroids or any illicit or recreational drugs
•4. Currently taking any antibiotics, probiotics or medication known to impact study outcomes
•5. Actively trying to lose weight which included participating in diets that would impact study outcomes (ketogenic or low carbohydrate diet)

发起方

TSI Group